Outpatient management of community-associated methicillin-resistant staphylococcus aureus skin and soft tissue infection

Journal of Pediatric Health Care

Volumn 25, Issue 5, 2011, Pages 308-315

  NeVille Swensen, Melissa ^a   Clayton, Margaret ^b  

^a WEBER STATE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

CA MRSA; Community acquired methicillin resistant Staphylococcus aureus; Community associated methicillin resistant Staphylococcus aureus; Skin and soft tissue infection

Indexed keywords

ALGORITHM; ARTICLE; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; OUTPATIENT; PREVALENCE; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

ALGORITHMS; HUMANS; INCIDENCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OUTPATIENTS; PREVALENCE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

EID: 80051911851     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2010.05.005     Document Type: Article

References (29)

1. Abrams, T., Bancroft, E., Apgar, F., Belmusto, V. E., Blake, R., Blumberg, D., ... Blumber, D. (2008). CA-MRSA: California's call to action. Retrieved from http://www.aware.md/HealthcareProfessional/CAMRSA.
2. Association for Professionals in Infection and Epidemiology. (2007). National prevalence study of methicillin-resistant Staphylococcus aureus (MRSA) in U.S. healthcare facilities. Retrieved from http://www.APIC.org.
3. Brandon, C., Cecil, B., Weaver, C., Heaton, L., Todd, N., & Simmons, B. (2008). Methicillin-resistant Staphylococcus aureus infection: Program report and recommendations of the Tennessee Department of Health and the Infectious Task Force. Retrieved from http://www.health.state.tn.us.com.
4. Bradley J.S., Nelson J.D. 2008-2009 Nelson's pocket book of pediatric antimicrobial therapy 2008, Alliance for World Wide Editing, Buenos Aires, Argentina. 17 ed.
5. Centers for Disease Control and Prevention. (2007). Outpatient management of skin and soft tissue infections in the era of community-associated MRSA. Retrieved from http://www.cdc.gov/MRSA.
6. D'Agata E.M., Webb G.F., Horn M.A., Mollering R.C., Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clinical Infection Diseases 2009, 48:274-284.
7. Dellit, T.H., & Duchin, J. (2007). Guidelines forevaluation and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in outpatient settings. Retrieved from http://www.doh.wa.gov/Topics/Antibiotics/providers.htm.
8. Deuremberg R.H., Vink C., Kalenic S., Friedrich A.W., Bruggerman C.A., Stobberingh E.E. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clinical Microbiology 2006, 13:222-235.
9. Drews T.D., Temte J.L., Fox B.C. Community-associated methicillin-resistant Staphylococcus aureus: Review of an emerging health concern. Wisconsin Medical Journal 2006, 105:52-57.
10. Elliott D.J., Zaoutis T.E., Troxel A.B., Loh A., Keren R. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Pediatrics 2009, 123(6):E959-E966.
11. Farley J.E. Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. American Academy of Nurse Practitioners 2008, 20:85-92.
12. Fey P.D., Said-Salim B., Rupp M.E., Hinrichs S.H., Boxrud D.J., Schlievert P.M., et al. Comparative molecular analysis of community or hospital acquired methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2003, 47:196-203.
13. File T.M. Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting. Cleveland Clinic Journal of Medicine 2007, 74:S6-S10.
14. Fisher R.G., Chain R.L., Hair P.S. Hypochlorite killing of community-acquired methicillin-resistant Staphylococcus aureus. Journal of Pediatric Infectious Disease 2008, 27:934-935.
15. Gorwitz R.J. A review of community-associated methicillin-resistant Staphylococcus aureus and soft tissue infections. Pediatric Infectious Disease Journal 2008, 27:1-5.
16. Gorwitz, R.J., Jernigan, D.B., Powers, J.H., Jernigan, J.A., and Participants in the Centers for Disease Control and Prevention-Convened Experts' Meeting on Management of MRSA in the Community. (2006). Strategies for clinical management of MRSA in the community. Retrieved from http://www.cdc.gov.
17. Hersch A.L., Henry F., Chambers M.D., Maselli J.H., Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft tissue infections. Archives of Internal Medicine 2008, 168:1585-1591.
18. Huang H., Flynn N.M., King J.H., Monchaud C., Morita M., Cohen S.H. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MRSA infections in Sacramento, California. Journal of Clinical Microbiology 2006, 44:2423-2427.
19. Le J., Lieberman J.M. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Journal of Pharmacotherapy 2006, 26:1758-1770.
20. Olesevich M., Kennedy A. Emergence of community-acquired methicillin-resistant Staphylococcus aureus soft tissue infection. Journal of Pediatric Surgery 2006, 42:765-768.
21. Pope N.D. Methicillin-resistant Staphylococcus aureus skin and soft tissue infections. US Pharmacology 2009, 34:HS8-HS15.
22. Popovich K.J., Hota B. Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Dermatologic Therapy 2008, 21:167-169.
23. Raygada J.L., Levine D.P. Managing CA-MRSA infections: Current and emerging options. Infections in Medicine 2009, 26:49-58.
24. Sanchez P.J. CA-MRSA: Preventing, managing leading culprit in skin, soft tissue infections. Infectious Disease News 2009, March, Retrieved from. http://infectiousdiseasenews.com/article.aspx?id=37804.
25. Siberry G.K. The Harriet Lane Handbook 2000, Mosby, St. Louis, MO. 15th ed.
26. Stroube R. CA-MRSA: How should we respond to outbreaks. Medscape 2008, Retrieved from. http://www.medscape.com.wa.
27. Stevens D.L., Bisno A.L., Chambers H.F., Everett E.D., Dellinger P., Wade J.C., et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections. Clinical Infectious Diseases 2005, 41:1373-1380.
28. Taketomo C.K., Hodding J.H., Kraus D.M. Pediatric dosage handbook 2009, Lexi-Comp, Hudson, Ohio. 6th ed.
29. Wilson B.A., Shannon M.T., Shields K.M. Pearson Nurses Drug Guide 2011, Pearson, New York.